Stem cell news. In this case, wound closure succes
Post# of 5066
OSIR literally double it's market cap today. Granted, it hasn't diluted itself like BMSN has and their product is approved. Maybe BMSN can one day be like OSIR.
http://www.reuters.com/article/2013/08/13/us-...amp;rpc=43